SCHEMBL1796249

SCHEMBL1796249

Cc1sc(NC(=O)COCC(=O)O)c(C(=O)OC(C)(C)C)c1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.53
HPGD P15428 3/20 0.53
LMNA P02545 6/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
KDM4E B2RXH2 3/20 0.51
THRB P10828 5/20 0.49
HTT P42858 3/20 0.49
GAA P10253 1/20 0.48
MAPT P10636 7/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PTBP1 P26599 1/20 0.45
NPSR1 Q6W5P4 3/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
ATM Q13315 1/20 0.43
GRM6 O15303 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
CRHBP P24387 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1795054 0.97 ALDH1A1 (0.53) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1797214 0.94 ALDH1A1 (0.50) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1797940 0.91 ALDH1A1 (0.45) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1798768 0.89 ALDH1A1 (0.42) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1799596 0.88 ALDH1A1 (0.45) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1802068 0.84 SERPINE1 (0.45) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1798224 0.84 KDM4E (0.42) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1797219 0.83 ALDH1A1 (0.59) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1795271 0.81 SERPINE1 (0.50) ALDH1A1HPGDLMNASMN1; SMN2KDM4E
SCHEMBL1795932 0.77 ALDH1A1 (0.64) ALDH1A1HPGDLMNASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 800/4885HPGD 920/4885LMNA 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.